section name header

Appendix 69.2

ElementComment
Clinical features

Preceding use of neuroleptic (usually develops within two weeks of starting medication)

Agitated delirium progressing to stupor and coma

Generalized lead-pipe muscular rigidity, often accompanied by tremor

Temperature >38 °C (may be >40 °C)

Autonomic instability: tachycardia, labile or high blood pressure, tachypnoea, sweating

CT brain

Typically normal

CSF findings

Typically normal

May show raised protein

Electroencephalography

Generalized slow wave activity

Blood tests

High creatine kinase (typically >1000 units/L, and proportionate to rigidity)

High white cell count (10–40 × 109/L)

Electrolyte derangements and raised creatinine common

Low serum iron level

Management

Stop neuroleptic

Supportive care

Use benzodiazepine if needed to control agitation

Consider use of dantrolene, bromocriptine or amantadine

Seek expert advice from a neurologist